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Background: A phantom shock—the sensation of an implantable cardioverter defibrillator (ICD)
discharge in the absence of an actual discharge—is a phenomenon that can occur in ICD patients. Little
is known about the influence of psychological factors on the incidence of phantom shocks. We evaluated
psychological correlates of phantom shocks 2 years post-ICD implant in a cohort of Dutch ICD recipients.
Methods: Consecutive patients (N = 300; 87.5% men; mean age = 62.3) willing to participate in a
prospective study (Twente ICD Cohort Study) on psychological factors in ICD recipients received an ICD
between September 2007 and February 2010. At baseline, patients complete the 36-item Short FormHealth
Survey, Hospital Anxiety and Depression Scale, and the Type D Scale. Lifetime presence of anxiety and
depression was assessed with the MINI structural interview.
Results: During a follow-up of 24 months, 16 patients (5.4%) experienced a phantom shock. Median
time to (first) phantom shock was 13 weeks (range 0–48 weeks). In univariable analysis, no significant
relationships were found between clinical or psychological indices and the occurrence of phantom shocks,
nor was there an association between phantom shocks and type D personality, symptoms of anxiety, or a
history of anxiety and depression.
Conclusions: Neither symptoms of anxiety and depression nor psychiatric history were associated with
the occurrence of phantom shocks. Further studies usingmore explorative, qualitative research techniques
are warranted to examine the correlates of phantom shocks. (PACE 2014; 37:768–773)
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Introduction
The implantable cardioverter defibrillator
(ICD) is the first-line treatment for the prevention
of sudden cardiac death (SCD) both as primary
and secondary prevention.1–3 Following current
guidelines, both patients with a history of
aborted SCD and patients who are at high risk
for potentially life-threatening ventricular tach-
yarrhythmia are candidates for ICD implantation.4
ICDs are designed to prevent SCD by converting
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ventricular arrhythmia into a normal heart rhythm
by the use of antitachycardia pacing or shock
therapy.
Despite improvements in ICD technology,
complications still occur. Complications can be
implantation-related, device-related, or related to
the clinical condition.5 Furthermore, a minority
of patients suffer from psychological distress
postimplant,4,5 although there is evidence to
suggest that the postimplantantion level remains
similar to the preimplantation level in around
80% of patients.6 Anxiety symptoms are expe-
rienced in 13–46% of ICD patients and 24–46%
report depressive symptoms.6 ICD shocks,7,8 heart
failure,9 and a type D personality (the tendency to
experience increased levels of anxiety, irritation,
and depressed mood across situations and time,
while not sharing these emotions with others
because of fear of disapproval),10,11 have been
identified as important correlates of psychological
distress and poor health-related quality of life
(HQOL).
©2014 Wiley Periodicals, Inc.
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One of the more unfamiliar, but established,
complications of living with an ICD is the
occurrence of a phantom shock.12 In the case of
a phantom shock, ICD patients subjectively feel
that they have received a shock while there has
been no actual ICD discharge.13 The incidence of
phantom shocks in ICD recipients is relatively
unknown, as are the risk factors. Prevalence of
phantom shocks has been investigated in three
studies, and ranges from 5.1% in a population of
general ICD recipients to 21.4% in young adults
(<30 years) with an ICD.14–16 The occurrence
of phantom shocks was not associated with
age, gender, left ventricular ejection fraction,
number of shocks, or appropriate shocks versus
inappropriate shocks,16 although one study found
that in primary prevention patients, a history of
atrial fibrillation and New York Heart Association
(NYHA) functional class< III were associatedwith
the occurrence of phantom shocks.14
A paucity of studies has focused on the psy-
chological indices of the occurrence of phantom
shocks. No literature was found on the effect of
phantom shocks on HQOL, but Prudente et al.,
and more recently Jacob et al., found that the
experience of a phantom shock was associated
with higher levels of anxiety and depression.17,18
However, given the retrospective nature of their
studies, it is still unclear whether phantom
shock is a manifestation of anxiety or depression
and whether phantom shock is contributing to
maladjustment to the ICD. A clear cause and
effect relationship between phantom shocks and
clinical or psychological factors has not yet been
established.
The aim of this study was to investigate
clinical and psychological indices as predictors of
phantom shocks. We hypothesized that patients
with a history of anxiety or depression, a
distressed (type D) personality, lower HQOL,
or symptoms of anxiety or depression at the
time of implantation have an increased risk of
experiencing phantom shocks in the first 2 years
following ICD implantation.
Methods
Patients and Design
The study population consisted of a con-
secutive cohort of patients implanted with an
ICD at Medisch Spectrum Twente, Enschede, the
Netherlands, between September 2007 and April
2010, as part of the Twente ICD Cohort Study
(TICS, trial register number NL13939.044.06).
The TICS study was designed to examine the
value of biomedical and psychological risk
markers for predicting life-threatening ventricular
arrhythmias requiring ICD therapy. Patients were
eligible for study participation if they met the
following inclusion criteria: (1) indication for a
first ICD implantation according to the guidelines
of the Netherlands Society of Cardiology and the
European Society of Cardiology4,19,20; (2) age ≥ 18
years; and (3) providing written informed consent.
Exclusion criteria were inability to read or write
Dutch, congenital heart disease, major psychiatric
disorders other than affective spectrum disorders
(e.g., psychosis, dementia), and participation in
other studies. After implantation, regular visits to
the ICD outpatient clinic were scheduled every
3–6 months and after every experienced ICD
discharge. Phantom shocks were defined as the
experience of an ICD discharge reported by the
patient, without an actual ICD discharge seen by
device interrogation.
The study was conducted according to the
Helsinki Declaration and the research protocol
was approved by the local ethics committee. All
patients provided written informed consent.
Demographic and Clinical Characteristics
Information on demographic and clinical
data was captured from the patients’ medical
records. Demographic variables included gender
and age. Clinical variables included indication
for ICD implantation (i.e., primary versus sec-
ondary), etiology (i.e., ischemic vs nonischemic),
comorbidity (i.e., chronic obstructive pulmonary
disease, hypertension, diabetes mellitus), NYHA
class, and the occurrence of shocks. Information
on current smoking status and alcohol use was
collected through a questionnaire.
Psychological Measurements
All patients completed a set of validated
questionnaires (see below) at baseline, prior to ICD
implantation.
Personality
Type D personality was measured with the
14-item Type D Scale (DS14),21 which is a self-
report questionnaire assessing the personality
traits negative affectivity (seven items; e.g., “I
often feel unhappy”) and social inhibition (seven
items; e.g., “I am a closed kind of person”).
Items are answered on a 5-point Likert scale
from 0 (not true) to 4 (true), with scores ranging
from 0 to 28 for both subscales. Type D case is
defined by a score of ≥10 on both subscales,21
with this cutoff being the most optimal according
to item response theory.22 The DS14 has good
psychometric properties with Cronbach’s α =
0.88/0.86 and 3-month test-retest reliability =
0.72/0.82 for the negative affect and the social
inhibition subscales, respectively.21 Type D per-
sonality is not confounded by indicators of disease
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severity, such as left ventricular dysfunction, in
postmyocardial infarction patients,23,24 nor by
NYHA functional class in patients with heart
failure.25
General Anxiety and Depression
Symptoms of anxiety and depression were as-
sessed using the Hospital Anxiety and Depression
Scale (HADS).26 The HADS is a validated self-
report measure consisting of 14 questions about
symptoms of anxiety and depression. Items are an-
swered on a 4-point Likert scale (0–3), with a score
range of 0–21 for both anxiety and depression.
A higher score indicates higher levels of anxiety
or depression. The HADS has been sufficient for
good psychometric properties, as indicated by
Cronbach’s α = 0.71 and 0.90 for the anxiety and
depression subscales, respectively, and test-retest
reliability of 0.86 and 0.91, respectively.27
Psychiatric History
History of depressive disorder or anxiety
disorder was measured with the Dutch version of
theMini International Neuropsychiatric Interview
(MINI).28,29 This is a structured diagnostic inter-
view that systematically determines psychiatric
diagnoses. It was developed to meet the need for a
short but accurate structured psychiatric interview
for multicenter clinical trials and epidemiological
studies, addressing the feasibility shortcomings of
two other frequently used structured psychiatric
interviews, the Structured Clinical Interview for
DSM-IV-TR Axis I (SCID-I) and the Composite
International Diagnostic Interview (CIDI). In this
study, only the parts relating to depressive
disorder and anxiety disorder were administered.
Test-retest reliability Kappa scores are 0.89 and
0.79, and interrater Kappa scores are 1.00 and 0.97,
respectively.28
Health-Related Quality of Life
HQOL was assessed with the 36-item Short
Form Health Survey (SF-36).30 The SF-36 is a
self-report measure composed of eight multi-
item scales: physical functioning, social function-
ing, vitality, role limitations regarding physical
problems, role limitations regarding emotional
problems, general mental health, bodily pain, and
general health perception. The raw scale scores
are transformed into a scale ranging from 0 to 100,
with a higher score indicative of a better HQOL
(and absence of pain for the Bodily pain scale).
The SF-36 has good psychometric properties, with
Cronbach’s α ranging from 0.78 to 0.93 for the
separate subscales in a sample of 4,172 Dutch
adults.30
Statistical Analysis
Differences in demographic and clinical
characteristics between groups were analyzed
using Student’s t-tests, Wilcoxon Signed-Ranks
test, χ2 tests, or Fisher’s exact test, as appropriate.
To examine risk factors for the occurrence of
phantom shocks, each variable was first entered
into a univariable analysis with the occurrence of
phantom shocks as the dependent variables.
Multivariable logistic regression analysis was
performed to investigate the relationship between
phantom shocks and type D personality, psy-
chiatric history, anxiety or depressive symptoms
prior to ICD implantation, and HQOL domains. A
priori based on the literature, we chose to include
sex, age, ICD indication, etiology, andNYHA func-
tional class in adjusted analysis. Variables were
removed from themodels, based on their statistical
significance, to obtain parsimonious models. For
this, a P value of<0.05was considered statistically
significant. All analyses were performed with
SPSS 15.01 (IBM Corp., Armonk, NY, USA).
Results
Baseline Characteristics of the Total Sample and
Stratified by Phantom Shock
From September 2007 until March 2010, 503
patients received an ICD at Medical Spectrum
Twente, Enschede, the Netherlands. Of 347
eligible patients, 47 patients refused to participate.
No data are available on differences between
participants and nonparticipants in baseline char-
acteristics. The remaining 300 patients (83.4%
men, mean age = 62.3 ± 11 years) were included
in the TICS and informed consent was obtained.
Patients were followed for 24 months after
ICD implantation. During follow-up, 43 patients
died and 26 patients withdrew their informed
consent, due to various personal reasons. Baseline
characteristics for the total sample and stratified
by phantom shock are shown in Table I.
Demographic and Clinical Variables and the
Occurrence of Phantom Shocks
Phantom shocks were experienced by 16
patients (5.4%; see Table I). The mean time to
phantom shock was 13 weeks (range 0–48 weeks).
In univariable analysis, no demographic or clinical
variables, including appropriate or inappropriate
shocks, were significantly associated with the
occurrence of phantom shocks. A weak trend was
found for phantom shocks and NYHA functional
class < III (P = 0.131).
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Table I.
Patient Characteristics Stratified by Phantom Shock† (N = 300)
Phantom Shock No Phantom Shock
N (%) N = 16 (5.4) N = 284 (94.6) P Value
Age Mean (SD) 58.4 (15.0) 62.5 (11.0) 0.300
Gender
Male 14 (87.5) 233 (82.0) 0.746
Female 2 (12.5) 51 (18.0)
Clinical variables, N (%)
Primary ICD indication 12 (75.0) 200 (70.4) 1.000
Ischemic heart disease 12 (75.0) 173 (60.9) 0.303
Smoking 3 (18.8) 62 (21.8) 1.000
Comorbidity‡ 7 (43.8) 137 (48.2) 0.727
NYHA class < III 15 (93.8) 208 (73.2) 0.131
Prior shock therapy
Appropriate shock, N (%) 2 (12.5) 38 (13.4) 0.651
Inappropriate shock, N (%) 1 (6.3) 18 (6.3) 0.651
Psychological variables
Psychological symptoms, HADS§ (N = 267)
Anxiety symptoms, Mean (SD) 5.8 (4.4) 5.4 (3.7) 0.685
Depressive symptoms, Mean (SD) 3.5 (4.8) 4.4 (3.4) 0.368
Personality, DS14¶ (N = 279)
Type D personality 1 (7.1) 58 (21.9) 0.314
Negative affectivity, mean (SD) 6.6 (6.1) 7.6 (6.3) 0.586
Social inhibition, mean (SD) 5.9 (4.7) 8.3 (6.0) 0.143
Psychiatric history, MINI†† (N = 290)
History of anxiety disorder 3 (20.0) 21 (7.6) 0.117
History of depressive disorder 2 (13.6) 53 (19.3) 0.744
Quality of life, SF36‡‡ Mean (SD) (N = 263)
Physical functioning 61.4 (31.3) 59.5 (27.9) 0.803
Social functioning 69.6 (34.7) 17.2 (28.2) 0.844
Role limitations (physical) 57.1 (46.4) 43.3 (44.4) 0.260
Role limitations (emotional) 78.6 (33.6) 66.1 (41.8) 0.203
Mental health 75.1 (19.0) 73.9 (19.3) 0.808
Vitality 56.1 (22.5) 56.6 (22.3) 0.932
Bodily pain 78.7 (23.0) 74.5 (27.5) 0.577
General health 47.9 (16.4) 51.8 (20.5) 0.481
†Presented as n (%) unless otherwise indicated.
‡Chronic obstructive pulmonary disease (COPD), hypertension, and/or diabetes.
§Hospital Anxiety and Depression Scale (HADS), administered prior to ICD implantation.
¶Type D caseness, as assessed with the Type D Scale (DS14), administered prior to ICD implantation.
††Mini International Neuropsychiatric Interview, administered prior to ICD implantation.
‡‡Short Form Health Survey-36 (SF-36), administered prior to ICD implantation.
ICD = implantable cardioverter defibrillator; NYHA = New York Heart Association; SD = standard deviation.
Psychological Variables and the Occurrence of
Phantom Shocks
No significant associations were found be-
tween phantom shocks and depressive or anxiety
symptoms or the presence of type D personality
(Table I). However, a weak trend was found for
patients with a lower score on the DS14 subscale
Social inhibition and phantom shocks (P = 0.143).
Another weak trend was found for the association
between history of an anxiety disorder and the
occurrence of phantom shocks (P = 0.117).
HQOL and the Occurrence of Phantom Shocks
No associations were found between HQOL
subscales and phantom shocks.
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Predictors of the Occurrence of Phantom Shocks
(Multivariable Analysis)
All variables with a P value lower than 0.15
were entered in a logistic regression analysis.
However, none of the variables, history of anxiety
disorder (Odds Ratio [OR] 2.47; 95% confidence
interval [95% CI] 0.50–12.36; P = 0.270), social
inhibition (OR 1.08; 95% CI 0.97–1.20; P = 0.159),
or NYHA functional class > III (OR 4.3; 95% CI
0.56–33.9; P = 0.163), were significant correlates
of the occurrence of phantom shocks.
Discussion
In this study, we examined psychological
predictors for the occurrence of phantom shocks
in a cohort of first-time ICD recipients. During
a follow-up period of 24 months, 5.4% of
patients reported the sensation of a phantom
shock. Although some studies have previously
addressed the psychological consequences asso-
ciated with phantom shocks,17,18 this is the first
study to examine psychological predictors for the
occurrence of phantom shocks. The results of
our study show that there are trends between
some of the psychological factors and phantom
shocks, but these were not significant and were
weak trends: we found that psychiatric history
and some type D personality traits were weakly
associatedwith the occurrence of phantom shocks.
However, anxiety or depression symptoms and
HQOL at baselinewere not significantly associated
with the occurrence of phantom shocks. Nor
did we find any other significant associations
between demographic or clinical variables and
the occurrence of phantom shocks. Our initial
hypothesis was not supported, but the results
may serve as hypothesis-generating, and that it
would be worthwhile to pursue whether there
is an association between these factors and
the occurrence of phantom shocks in larger
studies.
The weak trend that was found for history
of an anxiety disorder and lower scores on the
DS14 subscale social inhibition raises the question
whether the focus of research on phantom
shocks should be on psychological traits (i.e.,
personality traits or anxiety sensitivity) instead
of psychological states (i.e., symptoms of anxiety
and depression). The construct somatosensory
amplification (the tendency to perceive benign
somatic sensations or minor physical problems
and to label them as symptoms requiring medical
intervention)31 could be of interest when studying
the influence of psychological factors on the
occurrence of phantom shocks. In that case,
phantom shocks could be considered and regarded
as a consequence of somatosensory sensitivity.
Further research is needed to examine this
hypothesis, as in clinical practice, knowledge
of the patient’s psychological traits may help
healthcare professionals in managing and caring
for ICD patients more optimally.
This study adds to the findings of previous
studies in ICD patients focusing on psychological
characteristics and the occurrence of phantom
shocks by using a prospective study design,
enabling hypotheses about cause and effect.
Although most studies used a cross-sectional
study design,17,18 we followed our cohort from the
moment of ICD implantation until the end of the
follow-up period 2 years later.
This study has some limitations that should
be taken into consideration when interpreting
the results. First, in the assessment of anxiety
and depressive symptoms, type D personality
andHQOL patients used self-rating questionnaires
instead of a clinical diagnostic interview. We
emphasized confidentiality to counter any effect
of patient’s tendency to response in a social
desirable manner. Furthermore, in a recent review
it was found that due to the presence of a strong
general factor, the HADS might not distinguish
well enough between symptoms of anxiety and
depression, although the bifactor structure of the
HADS was confirmed.32 Second, gender and age
are the only sociodemographic variables included
in this study. Other variables, such as social status,
educational level, marital status, etc., may also
have had a role in the occurrence of phantom
shocks, and should be included in future research.
Third, a possible explanation for not finding
a significant association between psychological
indices and the occurrence of phantom shocks
might be due to the relatively small incidence
of phantom shocks in our population. This could
have led to a reduced chance to identify relevant
predictors for the occurrence of phantom shocks.
The absolute differences in DS14 subscale social
inhibition, history of an anxiety disorder, and
NYHA functional class < III between those with
and without phantom shocks, however, might
potentially be of clinical relevance.
In conclusion, this study showed that ICD
patients reporting a phantom shock do not seem
to have a significantly different demographic,
psychological, or clinical profile compared to
patients who did not report a phantom shock:
no significant associations were found between
medical status, anxiety and depressive symptoms,
HQOL, psychiatric history, typeDpersonality, and
phantom shocks. In order to better understand
the underlying factors that play a role in the
occurrence of phantom shocks, future studies
could be focusing on the role of somatosen-
sory amplification, or include more qualitative
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research techniques. An explorative, in-depth
structured interview could be used, focusing on
how the patient experienced the occurrence of
the phantom shock, what his or her perspective
is on the phantom shock, and how the patient
describes precipitating events. Through rating the
answer patterns using content analyses, it would
be possible to generate new hypotheses for future
studies examining the occurrence of phantom
shocks and its correlates.
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